Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bio Green Med Solution (BGMS) EBT Margin (2016 - 2025)

Historic EBT Margin for Bio Green Med Solution (BGMS) over the last 12 years, with Q3 2025 value amounting to 1219.75%.

  • Bio Green Med Solution's EBT Margin rose 204502500.0% to 1219.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 5282.72%, marking a year-over-year increase of 161078200.0%. This contributed to the annual value of 27976.74% for FY2024, which is 218931700.0% down from last year.
  • According to the latest figures from Q3 2025, Bio Green Med Solution's EBT Margin is 1219.75%, which was up 204502500.0% from 21670.0% recorded in Q3 2024.
  • Bio Green Med Solution's EBT Margin's 5-year high stood at 1219.75% during Q3 2025, with a 5-year trough of 91725.0% in Q2 2024.
  • Over the past 3 years, Bio Green Med Solution's median EBT Margin value was 18364.52% (recorded in 2023), while the average stood at 27328.51%.
  • In the last 5 years, Bio Green Med Solution's EBT Margin tumbled by -901073100bps in 2024 and then skyrocketed by 204502500bps in 2025.
  • Quarter analysis of 3 years shows Bio Green Med Solution's EBT Margin stood at 18364.52% in 2023, then dropped by -18bps to 21670.0% in 2024, then surged by 94bps to 1219.75% in 2025.
  • Its EBT Margin was 1219.75% in Q3 2025, compared to 21670.0% in Q3 2024 and 91725.0% in Q2 2024.